Skip to content

Mindfulness Interventions and Chronic Widespread Pain in Adolescents

CompletedNot applicableNCT02190474
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The primary objective of this study to determine the feasibility and acceptability of a mindfulness intervention for adolescents with juvenile fibromyalgia/ chronic widespread pain and other similar chronic symptoms.

Study details

Official title
Mindfulness Interventions and Chronic Symptoms
Interventions
  • Behavioral: Mindfulness Group
Sponsor
Yale University
Collaborators
National Institutes of Health (NIH); National Center for Complementary and Integrative Health (NCCIH)
Start date
2014-07
Primary completion
2016-12
Sex
All
Age range
from 12 Years to 17 Years
Results posted
No results posted in this snapshot
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * 2010 American College of Rheumatology (ACR) criteria based on the Widespread Pain Index (WPI) and Symptom Severity (SS) checklist. * Functional Disability Score ≥13 indicating at least moderate disability * Average pain intensity in the past week ≥ 4 on a 0-10 cm Visual Analog Scale. * Access to mobile telephone/smartphone with text messaging plan in order to receive survey questions. * Chronic symptoms such as fatigue, pain, bowel dysfunction, perceived cognitive impairment, or other non-specific symptoms persisting for 3-months or more, severe enough to have led to more than one visit to a medical provider. These symptoms must have not been found to be due to a definable general medical disorder despite adequate evaluation. Exclusion Criteria: * Diagnosis of an autoimmune or rheumatologic disease * Current regular mindfulness meditation activity * Serious illness (including mental illness/psychopathology) within 90 days prior to screening * Inability or unwillingness of a parent to give consent/permission or child to assent * Current use of opioid analgesics * Current prescription for antidepressant medications * Screening positive on the Columbia Suicide Screen (CSS) * Active participation (weekly or more often) in a fibromyalgia or chronic disease support group

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02190474